| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |